Thermo Fisher Scientific Inc. Stock Bulgaria S.E.
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
536.3 EUR | -1.56% | -0.94% | +11.28% |
Sales 2024 * | 43.02B 39.66B | Sales 2025 * | 46.1B 42.5B | Capitalization | 223B 206B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.67B | Net income 2025 * | 6.97B 6.43B | EV / Sales 2024 * | 5.73 x |
Net Debt 2024 * | 23.49B 21.66B | Net Debt 2025 * | 19.14B 17.64B | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
36
x | P/E ratio 2025 * |
30.8
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | -1.56% | ||
1 week | -0.94% | ||
Current month | +0.05% | ||
1 month | +0.20% | ||
3 months | +2.27% | ||
6 months | +22.18% | ||
Current year | +11.28% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-28 | 527.5 | -1.64% |
24-05-27 | 536.3 | -1.56% |
24-05-23 | 544.8 | -0.62% |
24-05-22 | 548.2 | +1.26% |
24-05-21 | 541.4 | -1.34% |
End-of-day quote Bulgaria S.E., May 26, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B | |
+20.43% | 31.33B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock